Selinexor Support Group Launch image

Selinexor Support Group Launch

Jan 27, 2021
11:00AM - 12:00PM MST
Online Event
Overview
Are you or a loved one currently taking Selinexor as a part of your myeloma treatment regimen? This is a relatively new drug in the myeloma arsenal and both patients and providers are not very familiar with how to use it in the clinic. We are launching this group to provide support to patients on Selinexor and their caregivers. Hear from Dr. Jatin Shah, CMO of Karyopharm, speak about Selinexor, its approval process, and side effect management. While this event will be a formal presentation, future meetings within this chapter will be more of a casual conversation that will include several patients advocates who will help moderate a group discussion as we cover a wide breadth of Selinexor topics.
Agenda
11:00 AM
Introductions
Audrey Burton-Bethke
The purpose of the chapter is introduced. The featured speaker, Dr. Jatin Shah is introduced.
11:05 AM
Presentation
Dr. Jatin Shah and Jenny Ahlstrom
Dr. Shah and Jenny details about Selinexor such as what is being learned about side effect management, original FDA approval, and recent approval to move Selinexor into earlier lines of therapy. 
11:40 AM
Questions and Answers
Bob Sisneros and Audience
Our patient advocate, Bob Sisneros, will open the question and answer session with a couple of questions of his own. We then will open up the questions to the audience through the question and answer section and try to answer as many as we can. 
Speakers & Moderators
Healthtree contact Jennifer Ahlstrom

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Healthtree contact Robert (Bob) Sisneros

Robert (Bob) Sisneros

Bob was diagnosed with myeloma unexpectedly in 2015 through a traumatic experience. After recovering and a failed SCT, he is working his way through other chemotherapy cocktails. Bob is extremely charismatic, loves his wife and family, and is a coach for the Myeloma Crowd if you would like to connect with him. He believes in the power of hope and is a Patient Advocate for our Selinexor Support Group.

Healthtree contact Jatin Shah, MD

Jatin Shah, MD

Dr. Jatin Shah, M.D. is the Chief Medical Officer and Executive Vice President of Development at Karyopharm Therapeutics and has been since July of 2019. His responsibilities include the development of study protocols and clinical development plans. He prepares the regulatory documents and provides scientific and clinical input to each of the studies. Prior to that, Dr. Shah acted as Senior VP of Clinical Development and VP of Clinical Strategy at Karyopharm Therapeutics. He is the co-founder of the World Health Forum/World Myeloma Forum that was launched in February of 2017. Before those accomplishments, Dr. Shah was Director of the Myeloma Clinical and Translational Research in the Department of Lymphoma/Myeloma Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center.